CDKN2B and acute myeloid leukemia: Since p15INK4B is a cyclin-dependent kinase inhibitor which functions as a cell growth regulator by inhibiting cell cycle progression during the G1 phase, we next determined whether p15INK4B reactivation corresponded to changes in AML cell survival and/or proliferation.